The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111271979 11127197 9 F 20150327 20160824 20150521 20160831 EXP CA-ROCHE-1581326 ROCHE 53.02 YR F Y 0.00000 20160831 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111271979 11127197 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 150 MG SOLUTION FOR INJECTION
111271979 11127197 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0066B,S0001E,S0002F,S0003B 103976 SOLUTION FOR INJECTION
111271979 11127197 9 C VENTOLINE ALBUTEROL 1 Unknown U 0
111271979 11127197 10 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
111271979 11127197 11 C NASACORT TRIAMCINOLONE ACETONIDE 1 Unknown U 0
111271979 11127197 12 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown U 0
111271979 11127197 13 C PULMICORT TURBUHALER BUDESONIDE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111271979 11127197 1 Asthma
111271979 11127197 9 Product used for unknown indication
111271979 11127197 10 Product used for unknown indication
111271979 11127197 11 Product used for unknown indication
111271979 11127197 12 Product used for unknown indication
111271979 11127197 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
111271979 11127197 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111271979 11127197 Abasia
111271979 11127197 Aphasia
111271979 11127197 Blood pressure systolic increased
111271979 11127197 Cough
111271979 11127197 Fatigue
111271979 11127197 Food allergy
111271979 11127197 Gastrointestinal disorder
111271979 11127197 Headache
111271979 11127197 Heart rate increased
111271979 11127197 Intestinal polyp
111271979 11127197 Malaise
111271979 11127197 Nasopharyngitis
111271979 11127197 Pain
111271979 11127197 Pneumonia
111271979 11127197 Throat irritation
111271979 11127197 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111271979 11127197 1 20111216 0
111271979 11127197 2 20151118 0
111271979 11127197 3 20160113 0
111271979 11127197 4 20160504 0
111271979 11127197 5 20160601 0
111271979 11127197 6 20160629 0
111271979 11127197 7 20160727 0
111271979 11127197 8 20160824 0